Wang, Lin
Xie, Suhang
Bao, Tianjie
Zhu, Siyi
Liang, Qiu
Wang, Xiaoyi
Zhang, Ruishi
Xiang, Xiaona
Du, Chunping
He, Chengqi
Funding for this research was provided by:
National Natural Science Foundation of China (81972146)
Department of Science and Technology of Sichuan Province (2020YJ0210)
West China Hospital, Sichuan University (HXHL20001)
Article History
Received: 7 March 2021
Accepted: 5 May 2021
First Online: 22 May 2021
Declarations
:
: The Ethics Committee on Biomedical Research, West China Hospital of Sichuan University has approved this trial (identifier: 2020–945). Any modifications to the protocol will be represented on Chinese Clinical Trial Registry (chictr.org.cn). Each participant in this study will obtain a written informed consent before the allocation. Before baseline assessment, Wejuanxing (a platform of the online survey) will be used for collecting informed consent electronically, while the handwritten informed consent will be collected at the baseline assessment. Moreover, the participant and the main family supporter will sign the informed consent file.
: Not applicable.
: None.